Leucemia mieloide aguda MO: características clínicas y de laboratorio / Acute myeloid leukemia MO: clinical and laboratory features
Rev. méd. Chile
;
125(4): 433-7, abr. 1997. tab, ilus
Article
Dans Espagnol
| LILACS
| ID: lil-196287
RESUMO
Patients and methods:
Eight patients, our of 368, with acute myeloid leukemia that were studied in the Hematology Laboratory of a public hospital in Santiago, were classified as LMA-MO.Results:
Blast cell morphology was undifferentiated or of subtype FAB-L2 lymphoblastic leukemia with medium sized blasts, agranular basophilic cytoplasm, reticular nuclear chromatin and a prominent nucleolus. Cytochemical staining was negative for peroxidase and esterases, immunophenotyping showed the expression of one or more myeloid antigens (CD13, CD33) and was negative for lymphoid antigens. Immunocytochemical expression of myeloperoxidase was positive in the three cases where it was performed. Only one patient achieved complete remission and is free of disease after 36 months of follow up. All other patients died without obtaining remission, six shortly after the onser and one 12 months after.Conclusions:
The diagnosis of LMA-MO is essential considering its dismal prognosis
Recherche sur Google
Indice:
LILAS (Amériques)
Sujet Principal:
Leucémie myéloïde
Type d'étude:
Étude pronostique
Limites du sujet:
Femelle
/
Humains
/
Bébé
/
Mâle
/
Nouveau-né
langue:
Espagnol
Texte intégral:
Rev. méd. Chile
Thème du journal:
Médicament
Année:
1997
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS